We are delighted to inform you that Pharmaceutical Technology in Hospital Pharmacy (PTHP) has switched to the Open Access model, which means that all articles are now published under the Creative Commons (CC-BY) license. Please find more information about Article Processing Charges and funding options below.
Objective Pharmaceutical Technology in Hospital Pharmacy (PTHP) is an international Open Access journal dedicated to all aspects of pharmaceutical technology in hospitals. This includes pharmaceutical compounding procedure with sterile or non-sterile drug products (chemotherapies, CIVAS, capsules, gels, topical formulations, colloidal carriers, emulsions, eye drops and else), radiopharmaceuticals, sterilization techniques, analytical and biological procedures (stability studies, quality control), monitoring and validation of materials, techniques and environment. It also includes the determination of medical-device performances using technical experiments or modelization. The journal will particularly welcome new pharmaceutical formulations that can benefit hospitalized patients such as infants or aged persons.
Pharmaceutical compounding procedures
Analytical and biological procedures
Compounding and technical set-up of clinical trials in hospital pharmacies
Article formats Review Papers, Original Research Articles, Guidelines, Opinion Papers and Short Communications
Article processing charges (APCs) Each unsolicited article, which is accepted for publication in Pharmaceutical Technology in Hospital Pharmacy is subject to an Article Processing Charge of 1,650€. There are no submission charges.
Open Access sponsorship Please note that the GERPAC society funds the APCs for a limited number of manuscripts per year. When you submit your manuscript via ScholarOne, please indicate if you request APC funding by GERPAC. If you have any questions upfront regarding the sponsorship by GERPAC, please get in touch with the Editorial Office via email@example.com.
All papers are peer-reviewed independently by at least two different reviewers in a blind manner thus please make sure, that the main document of your manuscript does not contain author(s)´s data and affiliations (Those shall only be indicated on the cover page which will not be included to the peers´ review files)
EDITOR-IN-CHIEF Frédéric Lagarce, University Hospital Angers, France.
CO-EDITOR Sylvie Crauste-Manciet, University Hospital Center Bordeaux, France
EDITORIAL BOARD Pascal Bonnabry, Geneva University Hospitals, Switzerland Philippe Bourget, University Hospital Necker, Paris, France Jean-François Bussières, Hospital Sainte Justine, University Montréal, Canada Thomas Connor, National Institute for Occupational Safety and Health, Cincinnati, USA Jean-Daniel Hecq, University Hospital Dinant Godinne, Namur, Belgium Irene Krämer, Pharmacy Department at the Medical Center of Johannes Gutenberg-University Hospital, Mainz, Germany Franck Lacoeuille, University Hospital Angers, France Pascal Odou, Lille Regional University Hospital Centre, France Farshid Sadeghipour, University Hospital of Lausanne, Switzerland Valerie Sautou, University Hospital Center Clermont-Ferrand, France Rudolf Schierl, Ludwig Maximilian University of Munich, Germany Catherine Tuleu, University College London, United Kingdom Ewa Zygadlo, Drug Information Center, Wroclaw, Poland